B-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 43-51

  Matsumoto, Yoh ^a   Park, Il Kwon ^a   Kohyama, Kuniko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C; PROTEIN CC2; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CARRIER PROTEIN; EPITOPE; MYOSIN BINDING PROTEIN C; MYOSIN-BINDING PROTEIN C; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; CHEMISTRY; GENETICS; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; EPITOPES, B-LYMPHOCYTE; IMMUNIZATION; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MYOCARDITIS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 33847049545     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060544     Document Type: Article

References (22)

1. Liu PP, Mason JW: Advances in the understanding of myocarditis. Circulation 2001, 104:1076-1082
2. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO, Alling D, Wittes JT, Ferrnas VJ, Rodriguez ER, Fauci AS: A prospective, randomized, controlled trial of predonisone for dilated cardiomyopathy. N Engl J Med 1989, 321:1061-1068
3. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonske L, Rozek MM, Wodniecki J: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Circulation 2001, 104:39-45
4. Staudt A, Schaper F, Stangl V, Plagemann A, Bohm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB: Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001, 103:2681-2686
5. Matsumoto Y, Tsukada Y, Miyakoshi A, Sakuma H, Kohyama K: C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol 2004, 173:3535-3541
6. Edwards RJ, Singleton AM, Boobis AR, Davies DS: Cross-reaction of antibodies to coupling groups used in the production of anti-peptide antibodies. J Immunol Methods 1989, 117:215-220
7. Matsumoto Y, Jee Y, Sugisaki M: Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 2000, 164:2248-2254
8. Kim G, Tanuma N, Kojima T, Kohyama K, Suzuki Y, Kawazoe Y, Matsumoto Y: CDR3 size spectratyping and sequencing of spectra-type-derived T cell receptor of spinal cord T cells in autoimmune encephalomyelitis. J Immunol 1998, 160:509-513
9. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157
10. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD: Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995, 182:75-85
11. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS: Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997, 3:1133-1136
12. Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD: Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol 2000, 164:670-678
13. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E: Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol 1998, 161:6963-6969
14. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA: The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003, 197:1501-1510
15. Bischof F, Bins A, Durr M, Zevering Y, Melms A, Kruisbeek AM: A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response. J Immunol 2004, 173:600-606
16. Warraich RS, Dunn MJ, Yacoub MH: Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 1999, 259:255-261
17. Baba A, Yoshikawa T, Chino M, Murayama A, Mitani K, Nakagawa S, Fujii I, Shimada M, Akaishi M, Iwanaga S, Asakura Y, Fukuda K, Mitamura H, Ogawa S: Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. Jpn Circ J 2001, 65:867-873
18. Caforio AL, Mahon NJ, Tona F, McKenna WJ: Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002, 4:411-417
19. Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB: Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002, 106:2448-2453
20. Staudt A, Staudt Y, Dorr M, Bohm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB: Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004, 44:829-836
21. Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R: Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000, 101:385-391
22. Larsson L, Mobini R, Aukrust P, Gullestad L, Wallukat G, Waagstein F, Fu M: Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody. Autoimmunity 2004, 37:489-493